代表性论文

Cheng Chen; Li Wang; Lili Li; Aoli Wang; Tao Huang; Jie Hu; Ming Zhao; Feiyang Liu; Shuang Qi; Chen Hu; Wenliang Wang; Jing Liu; Jian Ge; Ruixiang Xia; Wenchao Wang; Qingsong Liu; Network-based analysis with primary cells reveals drug response landscape of acute myeloid leukemia, Experimental Cell Research, 2020, 393(1).

Jiang Zongru; Wang Li; Liu Xuesong; Chen Cheng; Wang Beilei; Wang Wenliang; Hu Chen; Yu Kailin; Qi Ziping; Liu Qingwang; Wang Aoli; Liu Jing; Hong Guangchen; Wang Wenchao; Liu Qingsong; Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel antiangiogenesis agent, Acta Pharmaceutica Sinica B, 2020, 10(3): 488-497.

Wang, Wenliang; Jiang, Zongru; Wang, Li; Wang, Aoli; Liu, Juan; Chen, Cheng; Yu, Kailin; Zou, Fengming; Wang, Wenchao; Liu, Jing; Liu, Qingsong; All-trans retinoic acid exerts selective anti-FLT3-ITD acute myeloid leukemia efficacy through downregulating Chk1 kinase, CANCER LETTERS, 2020, 473(31): 130-138.

Li Wang; Chen Hu; Aoli Wang; Cheng Chen; Jiaxin Wu; Zongru Jiang; Fengming Zou; Kailin Yu; Hong Wu; Juan Liu; Wenliang Wang; Zuowei Wang; Beilei Wang; Ziping Qi; Qingwang Liu; Wenchao Wang; Lili Li; Jian Ge; Jing Liu; Qingsong Liu; Discovery of a novel and highly selective CDK9 kinase inhibitor (JSH-009) with potent antitumor efficacy in preclinical acute myeloid leukemia models, Investigational New Drugs, 2019, null(null).

专利

刘青松; 刘静; 吴云; 汪文亮; 王蓓蕾; 齐紫平; 王俊杰; 王文超; 亓爽; 王黎; MST1激酶抑制剂及其用途, 2021-11-23, CN201910914334.2

刘青松; 刘静; 吴云; 王蓓蕾; 王傲莉; 胡晨; 刘青旺; 邹凤鸣; 王文超; 王作伟; 操江艳; 时辰亮; 王黎; 二氢异喹啉酮和异吲哚啉酮衍生物及其用途, 2021-10-21, CN202111227801

刘青松; 刘静; 梁小飞; 王蓓蕾; 余凯琳; 蒋宗儒; 陈程; 胡晨; 王文邹; 邹凤鸣; 刘青旺; 李凤; 汪文亮; 王黎; 一类嘧啶类衍生物激酶抑制剂, 2017-12-26, ZL201780004132

刘青松; 刘静; 李希祥; 王傲莉; 齐紫平; 吴宏; 吴佳昕; 王文超; 胡晨; 陈程; 王黎; 王蓓蕾; FLT3激酶的新型抑制剂及其用途, 2016-06-03, ZL201610409235